PLAY PODCASTS
HCC Surveillance: Challenges and Opportunities
Episode 140

HCC Surveillance: Challenges and Opportunities

Learn from the experts as they discuss challenges with implementing surveillance for hepatocellular carcinoma and emerging modalities to enhance surveillance programs.

Decera Clinical Education Oncology Podcast · David E. Kaplan MD MSc, Tamar Taddei MD

January 3, 202331m 24s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, David Kaplan, MD, MSc, and Tamar Taddei, MD, discuss which patients should be screened for hepatocellular carcinoma, current surveillance recommendations, barriers to implementation, emerging biomarkers in development, and unmet needs in hepatocellular carcinoma surveillance. 

Presenters:

David E. Kaplan, MD, MSc
Associate Professor
Perelman School of Medicine
Chief, Hepatology Section 
Division of Gastroenterology and Hepatology 
University of Pennsylvania
Director of Hepatology
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Tamar Taddei, MD
Professor 
Section of Digestive Diseases 
Department of Internal Medicine
Yale School of Medicine 
Chief, GI Section 
VA Connecticut Healthcare System
West Haven, Connecticut


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

ultrasoundcirrhosisaasld or american association for the study of liver diseasealpha-fetoprotein-l3nash or non-alcoholic steatohepatitisfib-4 or fibrosis-4dcp or des-gamma-carboxy prothrombinhepatocellular carcinomagalad or gender age afp afp-l3 and dcphepatitis bdavid kaplantamar taddeihepatitis cabbreviated mrinafld or non-alcoholic fatty liver diseasehccpivka-iialpha fetoproteinhcc surveillance